An interventional study of Collaborative care in Kidney Transplant, Depression and Pain, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 21 Years to 95 Years. Per ClinicalTrials.gov, last updated 2024-12-13.
Sponsored by University of Pittsburgh · Not applicable, Interventional, and Supportive care
The aims of the present study will be to pilot test the efficacy of a collaborative care intervention in patients awaiting kidney transplant to reduce symptoms of depression, pain, fatigue and improve quality of life.
Symptom management is critical to maintain quality of life in those with life limiting conditions. Stepped collaborative care interventions have been widely employed in the primary care setting for the treatment of depression and more recently have been utilized to treat other symptoms (e.g., pain) in a variety of settings. A recent meta-analyses concluded that collaborative care interventions were superior to usual care and are more cost-effective than face to face and pharmacological treatment for depression. Collaborative care interventions have begun to be extended to other settings but have not been tested in patients who are being treated with dialysis. The aims of the present study were to pilot test the efficacy of a collaborative care intervention in patients awaiting kidney transplant to reduce symptoms of depression, pain, fatigue and improve quality of life.
8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 10 is below the median of 84 across 6,869 interventional studies indexed under Depression.
Browse Depression studies →University of Pittsburgh is the lead sponsor of 1,414 studies on the registry; 168 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age 18 or older Currently receiving dialysis at UPMC dialysis facility for chronic kidney disease Fluent in English
Exclusion Criteria:
Under the age of 18 years or over 90 years Not fluent in English
To test the efficacy of a collaborative care intervention with patients treated with dialysis to reduce depression, pain, fatigue, and improve quality of life
Behavioral: Collaborative care
Therapist will use iPad (Vidyo) once a week during dialysis for approximately one hour. The therapist will teach the patient cognitive-behavioral strategies to manage their mood and pain. The PI is a clinical psychologist and will provide supervision to the therapist providing the intervention. The sessions for depression will include (1) intake, (2) review of the rational for using CBT to treat depression and/or pain, (3) identifying thought patterns, (4) changing thought patterns, (5) relaxation techniques, (6) rest-activity pacing, and (7) coping strategies. Homework to practice these techniques will be provided after each session.
Depression Level
score on CES-D questionnaire
Time frame: change from baseline at 3 month and 6 month
Perceived Stress level
score on PSS questionnaire
Time frame: change from baseline at 3 month and 6 month
degree of Pain
score on the BPI questionnaire
Time frame: change from baseline at 3 month and 6 month
Dyadic functioning
score on the Dyadic functioning questionnaire
Time frame: change from baseline at 3 month and 6 month
level of physical activity (mild, moderate or high)
calculated score on the International Physical Activity quationnaire
Time frame: change from baseline at 3 month and 6 month
sleep quality
score on the PSQI questionnaire
Time frame: change from baseline at 3 month and 6 month
quality of life
score on the KDQOL questionnaire
Time frame: change from baseline at 3 month and 6 month
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.